Global Asthma Treatment Market Size Covered By Global Analysis, Share, Segment, Type, Growth, Revenue Analysis Forecast 2028

Market Overview:

The global asthma treatment market size is expected to reach USD 26.01 billion by 2028, exhibiting a CAGR of 4.5% during the forecast period. The growing incidence of respiratory diseases such of chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, lung cancer, asthma, and pleural effusion will spur demand for asthma treatment during the forecast period, mentioned in a report, titled "Asthma Treatment Market Size, Share & Industry Analysis, By Treatment (Long-Term Control Medications, and Quick-Relief Medications), By Route of Administration (Injectable, Oral, and Inhaled), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2021-2028" the market size stood at USD 18.08 billion in 2019. The increasing risk of death in asthma patients amid the COVID-19 pandemic will fuel demand for pre-diagnosis, which, in turn, will aid the market. For instance, According to the Centers for Disease Control and Prevention (CDC), during the 2020-2021 coronavirus pandemic, individuals suffering from moderate to severe asthma, were at a greater risk of falling ill with acute respiratory disease.

Request for Free Sample Report PDF @ https://www.fortunebusinessinsights.com/enquiry/sample/asthma-treatment-market-101039

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Market Driver:
Surge in Asthma Cases to Expedite Business Expansion

The increasing prevalence of chronic respiratory diseases such as asthma has led to the expansion of the market during the forecast period. Asthma is considered to be the most common chronic disease worldwide. The growing need for advanced therapeutics will subsequently promote the growth of the market. According to the American Academy of Allergy, Asthma & Immunology (AAAAI), in the United States, in 2016, it was estimated that approximately 8.3% of children in the U.S. had asthma. The launch of low cost-effective therapeutics such as generic equivalents can be an essential factor in augmenting the growth of the market during the forecast period. The growing demand for asthma drugs due to the outbreak of coronavirus will significantly enable the healthy growth of the market. For instance, patients with chronic illnesses such as asthma are more prone to catch the virus. The Centres for Disease Control and Prevention (CDC), in the time of coronavirus pandemic, has issued special guidelines to patients of asthma and also advocated greater precaution for asthma patients.

Market Restraint:
Expensive Asthma Medications to Dwindle Market Growth

The high costs associated with asthma inhalers, which are often considered the primary treatment for Asthma will limit the adoption of asthma therapeutics. For instance, the prices of Advair, a critical asthma drug has risen from US$ 316 in 2013 to US$ 496 in 2018, documenting an increase of 56.0%. Furthermore, the under diagnosis of asthma in developing countries will subsequently restrict the growth of the market during the forecast period. Under diagnosis of asthma leads to poor clinical outcomes for the patient and the adoption of inappropriate asthma pharmaceuticals as a treatment for their medical condition. These factors together are likely to restrict the growth of the market.

Regional Analysis:
Rising Awareness Among Patients to Support Growth in North America

The market size in North America stood at USD 9.40 billion in 2019. The growth in the region is attributed to the rising prevalence of asthma and the awareness of advanced and efficient asthma therapeutics among patients. The market in Asia Pacific is likely to hold the largest share in the forthcoming years owing to the presence of key products in the region, For instance, the strong growth of Pulmicort, a key asthma drug in China. The increasing prevalence of chronic respiratory diseases and growing launches of key products including efficient generic asthma therapeutics is predicted to bode well for the market in Asia Pacific during the forecast period.

Ask for Customization @ https://www.fortunebusinessinsights.com/enquiry/customization/asthma-treatment-market-101039

Key Development:

September 2019: The U.S. FDA announced the regulatory approval for Nucala (mepolizumab) for the usage in children as young as the age of six, who are suffering from severe eosinophilic asthma.



The Report Lists the Main Companies in the Market:



AstraZeneca
GlaxoSmithKline plc
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Mylan N.V.
Boehringer Ingelheim International GmbH
Regeneron
Sanofi
Genentech, Inc. (F. Hoffmann-La Roche Ltd)
Novartis AG
Sumitomo Dainippon


Table Of Content:

Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Prevalence of Asthma - by Key Regions - 2019
Pipeline Analysis
Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
Regulatory Scenario - by Key Regions
An Overview of Emerging Treatments for Asthma
An Overview of Guidelines for the Diagnosis and Management of Asthma (EPR-3)
Reimbursement Scenario - by Key Regions
Global Asthma Treatment Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis, Insights and Forecast - By Treatment
Long-Term Control Medications
Quick-Relief Medications
Market Analysis, Insights and Forecast - By Route of Administration
Injectable
Oral
Inhaled
Market Analysis, Insights and Forecast - By Distribution Channel
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Online Pharmacies
Market Analysis, Insights and Forecast - By Region
North America
Europe
Asia pacific
Latin America
Middle East & Africa
North America Asthma Treatment Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis - By Treatment
Long-Term Control Medications
Quick-Relief Medications
Market Analysis - By Route of Administration
Injectable
Oral
Inhaled
Market Analysis - By Distribution Channel
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Online Pharmacies
Market Analysis - By Country
S.
Canada
Europe Asthma Treatment Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis - By Treatment
Long-Term Control Medications
Quick-Relief Medications
Market Analysis - By Route of Administration
Injectable
Oral
Inhaled
Market Analysis - By Distribution Channel
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Online Pharmacies
Market Analysis - By Country/ sub-region
K.
Germany
France
Spain
Italy
Scandinavia
Rest of Europe
Asia pacific Asthma Treatment Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis - By Treatment
Long-Term Control Medications
Quick-Relief Medications
Market Analysis - By Route of Administration
Injectable
Oral
Inhaled
Market Analysis - By Distribution Channel
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Online Pharmacies
Market Analysis - By Country/ sub-region
Japan
China
India
Australia
Southeast Asia
Rest of Asia Pacific
Latin America Asthma Treatment Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis - By Treatment
Long-Term Control Medications
Quick-Relief Medications
Market Analysis - By Route of Administration
Injectable
Oral
Inhaled
Market Analysis - By Distribution Channel
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Online Pharmacies
Market Analysis - By Country/ sub-region
Brazil
Mexico
Rest of Latin America
Middle East & Africa Asthma Treatment Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis - By Treatment
Long-Term Control Medications
Quick-Relief Medications
Market Analysis - By Route of Administration
Injectable
Oral
Inhaled
Market Analysis - By Distribution Channel
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Online Pharmacies
Market Analysis - By Country/ sub-region
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Analysis
Key Industry Developments
Global Market Share Analysis (2019)
Competition Dashboard
Comparative Analysis - Major Players
Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
AstraZeneca
GlaxoSmithKline plc
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Mylan N.V.
Boehringer Ingelheim International GmbH
Regeneron
Sanofi
Genentech, Inc. (F. Hoffmann-La Roche Ltd)
Novartis AG
Sumitomo Dainippon Pharma Co., Ltd.
Other Prominent Players
Strategic Recommendations
Continued. . .

Related Article @ https://marketresearchreportsfbi.wordpress.com/2021/11/08/global-trauma-implants-market-by-technology-share-size-segmentation-revenue-analysis-forecast-2028/

NOTE: Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

This release was published on openPR.